INTRODUCTION: Peritoneal tumor seeding is a common form of recurrence after gastric cancer surgery. The finding of free tumor cells and/or elevation of tumor markers in the peritoneal fluid could predict intraperitoneal tumor recurrence. The results of these examination can be used for indication of aggressive treatment modalities such as hyperthermic intraperitoneal chemotherapy (HIPEC). MATERIAL AND METHODS: We have operated on 105 patients suffering from gastric cancer. The control group consisted of 12 patients without malignant disease. Peritoneal lavage fluid or ascites was collected immediately after laparotomy and examined by cytology and biochemistry (levels of carcinoembryonic antigen (CEA) and Ca 19-9). Sensitivity, specificity, stage correlation and overall survival were observed. RESULTS: Elevation of tumor markers or the finding of free intraperitoneal tumor cells predicts recurrence. The prognosis of these patients is same as in stage IV TNM classification with median survival time less than 1 year (p = 0.713). Patients with negative cytology have median survival time 5 years contrary to them with positive cytology (p < 0.001). Sensitivity of the cytology was 34% and specificity was 85%. Sensitivity of biochemistry was 53% (combination of both markers) and specificity was 100%. CONCLUSIONS: This study confirms the importance of peritoneal fluid examination for the prognosis. We cannot recommend routine use as an indicator for HIPEC due to low sensitivity, but the result of cytological examination is an independent factor for patient survival.

Department of Surgery General University Hospital Prague Czech Republic

Department of Surgery Hospital Bulovka Prague Czech Republic

See more in PubMed

Aiko T, Sasako M. The new Japanese clasification of gastric carcinoma: points to be revised. Gastric Cancer. 1998;1:25–30. PubMed

Washington K. 7thEdition of the AJCC Cancer Staging Manual: Stomach. Ann Surg Oncol. 2010;17:3077–9. PubMed

Makary MA, Warshaw AL, Centeno BA, Willett CG, Rattner DW, del Castillo CF. Implications of peritoneal cytology for pancreatic cancer management. Arch Surg. 1998;133:361–5. PubMed

Marutsuka T, Shimda S, Shiomori K, Ogawa M. Peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma and prophylatic strategy for peritoneal dissemination. International Congress Series. 2003;1255:103–7. PubMed

Swan R, Miner TJ. Current role of surgical theray in gastric cancer. World J Gastroenterol. 2006;12:372–9. PubMed PMC

Nishiyama M, Takashima I, Tanaka T, et al. Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer. World J Surg. 1995;19:133–7. PubMed

Hayes N, Wayman J, Wadehra V, Scott DJ, Raimes SA, Griffin SM. Peritoneal cytology in the surgical evaluation of gastric carcinoma. Br J Cancer. 1999;79:520–4. PubMed PMC

Vogel P, Rüschoff J, Kümmel S, et al. Prognostic value of microscopic peritoneal dissemination. Dis Colon Rectum. 2000;43:92–100. PubMed

Wang JY, Lin SR, Lu CY, et al. Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus combined cytology with peritoneal carcinoembryonic antigen levels. Cancer Letters. 2005;223:129–35. PubMed

Wang Z, Hao B, Yang Y, Wang R, Li Y, Wu Q. Prognostic role of SPARC expression in gastric cancer: a meta-analysis. Arch Med Sci. 2014;10:863–9. PubMed PMC

Wang JY, Lin SR, Lu CY, et al. Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus combined cytology with peritoneal carcinoembryonic antigen levels. Cancer Lett. 2005;223:129–35. PubMed

Zhao K, Zhu BS, Gong W, et al. SN50 enhances the effects of LY294002 on cell death induction in gastric cancer cell line SGC7901. Arch Med Sci. 2013;9:990–8. PubMed PMC

Yu X, Luo L, Wu Y, et al. Gastric juice miR-129 as a potential biomarker for screening gastric cancer. Med Oncol. 2013;30:365. PubMed

Li JK, Zheng M, Miao CW, Zhang JH, Ding GH, Wu WS. Peritoneal lavage cytology and carcinoembryonic antigen determination in predicting peritoneal metastasis and prognosis of gastric cancer. World J Gastroenterol. 2005;46:7374–7. PubMed PMC

Majima T, Ichikura T, Mochizuki H. Prognostic significance of the cytologic features of free cancer cells in the peritoneal cavity of patints with gastric cancer. Surg Today. 2002;32:35–9. PubMed

de Manzoni G, Verlato G, di Leo A, et al. Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. World J Surg. 2006;30:579–84. PubMed

Ribeiro Jr U, Gama-Rodrigues JJ, Safatle-Ribeiro AV, et al. Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer. J Gastrointest Surg. 1998;2:244–9. PubMed

Sugarbaker PH. Adjuvant intraperitoneal chemotherapy for advanced primary gastric cancer. Scand J Surg. 2006;95:270–3. PubMed

Graziosi L, Marino E, Cavazzoni E, Donini A. Prognostic value of the seventh AJCC/UICC TNM classification of non-cardia gastric cancer. World J Surg Oncol. 2013;11:103. PubMed PMC

Bando E, Yonemura Y, Takeshita Y, et al. Intraoperative lavage for cytological examination in 1297 patients with gastric carcinoma. Am J Surg. 1999;178:256–62. PubMed

Bold R, Ota DM, Ajani JA, Mansfield PF. Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric cancer. Gastric Cancer. 1999;2:1–7. PubMed

Pressurised Intraperitoneal Aerosolised Chemotherapy-Results from the First Hundred Consecutive Procedures